Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment.

Trial Profile

Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 11 Aug 2012

At a glance

  • Drugs Daptomycin (Primary) ; Vancomycin
  • Indications Diabetic foot ulcer; Methicillin-resistant Staphylococcus aureus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 May 2012 New source identified and integrated (European Clinical Trials Databases; EudraCT2010-022348-18).
    • 26 Mar 2012 Actual patient number (1) added as reported by ClinicalTrials.gov.
    • 26 Mar 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top